跳至主要内容
临床试验/NCT01265420
NCT01265420已完成4 期

The Efficacy and Safety of Xiaflex Injections for the Treatment of Thumb Cords in Dupuytren's Contractures

Indiana Hand to Shoulder Center2 个研究点 分布在 1 个国家目标入组 7 人开始时间: 2010年12月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
7
试验地点
2
主要终点
Number Patients Obtaining Clinical Improvement (>50% Reduction in Contracture)

研究概览

简要总结

This study will evaluate the efficacy and safety of clostridial collagenase injections for treatment of Dupuytren's contracture of the thumb and first web space. The investigators hypothesis is that clostridial collagenase will have safety not significantly different to that demonstrated in Phase III clinical trials, and will be effective in significantly reducing the degree of thumb contracture.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult subjects (> 18 years) of either gender with an MP and/or IP joint contracture and a palpable cord of > 20 degrees of the thumb
  • First web space contracture with a palpable cord due to Dupuytren's contracture

排除标准

  • Prior surgical, percutaneous needle aponeurotomy or Xiaflex treatment for Dupuytren's contracture of the same thumb.
  • Any subject using anti-coagulant therapy other than low dose aspirin (up to 150mg/day).
  • Any subject in the opinion of the MD investigators with chronic, severe or terminal medical illness which would make them unsuitable for study participation.
  • Any subject with known allergy to Xiaflex (Clostridial collagenase).
  • Pregnant or nursing female
  • Any subject who cannot conform to the study visit schedule

结局指标

主要结局

Number Patients Obtaining Clinical Improvement (>50% Reduction in Contracture)

时间窗: 30 days after last injection

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

F. Thomas D. Kaplan, MD

MD

Indiana Hand to Shoulder Center

研究点 (2)

Loading locations...

相似试验